Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis
Ivone Cristina Igreja Sa, Vaclav Smid, Petra Fikrova, Jana Urbanková Rathouska, Ivana Nemeckova, Katarina Tripska, Adela Diepoltova, SeyedehNiloufar Mohammadi, Ctirad Andrys, Jaromir Petrtyl, Radan Bruha, Libor Vitek, Petr Nachtigal · 2026
Read Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis by Ivone Cristina Igreja Sa, Vaclav Smid, Petra Fikrova, Jana Urbanková Rathouska, Ivana Nemeckova, Katarina Tripska, Adela Diepoltova, SeyedehNiloufar Mohammadi, Ctirad Andrys, Jaromir Petrtyl, Radan Bruha, Libor Vitek, Petr Nachtigal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13324551.txt.
Description
Ivone Igreja Sa and co-authors test, in 2026, whether a blood marker can flag dangerous pressure buildup in the liver veins of cirrhosis patients. The standard check is invasive, threading a catheter into the liver. The candidate marker, soluble endoglin, reflects vessel lining damage and scarring. Sixty patients had both the blood test and the invasive measurement.
Marker levels ran clearly higher in patients than in healthy controls. Levels did not, however, track how severe the pressure was. They did track a liver enzyme and ran higher in patients who drank alcohol. The authors call the marker a sign of vessel damage rather than a pressure gauge.
Catalog record
| CREATOR | Ivone Cristina Igreja Sa, Vaclav Smid, Petra Fikrova, Jana Urbanková Rathouska, Ivana Nemeckova, Katarina Tripska, Adela Diepoltova, SeyedehNiloufar Mohammadi, Ctirad Andrys, Jaromir Petrtyl, Radan Bruha, Libor Vitek, Petr Nachtigal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |